You are using an older browser version. Please use a supported version for the best MSN experience.

Sinovac's COVID-19 vaccine induces quick immune response: study

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday (November 18). Bryan Wood reports.


image beaconimage beaconimage beacon